Tremor
54
13
13
27
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 54 trials
100.0%
+13.5% vs benchmark
11%
6 trials in Phase 3/4
33%
9 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (54)
Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor
Effect of Kinesiotaping on Tremor in People With Parkinson's Disease
Neurosurgical Outcome Network
Natural History Protocol for Movement Disorders
In Vivo Measurement of the Accuracy of the "Neurolocate" Module of the Neurosurgical Robot "Neuromate" in Its Application to Deep Brain Stimulation
Connectomic Guided DBS for Parkinson's Disease
A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
MRgFUS for Parkinson's Tremor
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
Observational Study on "Functional Overlay" in Patients With Movement Disorders
Trajectory of Immunosuppression-Caused Tremor In Kidney and Lung Transplant Recipients
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease
TRANSPARK_LONG: The Diagnostic Value of Early Transcranial Ultrasound in Patients With Extrapyramidal Diseases in a Swedish Population
Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor
Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach
Istradefylline Effect Protocol on Parkinson's Disease Tremor